Page last updated: 2024-11-07

spironolactone and Bone Loss, Osteoclastic

spironolactone has been researched along with Bone Loss, Osteoclastic in 4 studies

Spironolactone: A potassium sparing diuretic that acts by antagonism of aldosterone in the distal renal tubules. It is used mainly in the treatment of refractory edema in patients with congestive heart failure, nephrotic syndrome, or hepatic cirrhosis. Its effects on the endocrine system are utilized in the treatments of hirsutism and acne but they can lead to adverse effects. (From Martindale, The Extra Pharmacopoeia, 30th ed, p827)
spironolactone : A steroid lactone that is 17alpha-pregn-4-ene-21,17-carbolactone substituted by an oxo group at position 3 and an alpha-acetylsulfanyl group at position 7.

Research Excerpts

ExcerptRelevanceReference
"We hypothesized that aldosteronism is accompanied by hypercalciuria and hypermagnesuria that lead to bone loss, which could be rescued by hydrochlorothiazide and spironolactone."3.73Bone loss in rats with aldosteronism. ( Bhattacharya, SK; Chhokar, VS; Runyan, AL; Runyan, JW; Sun, Y; Weber, KT, 2005)

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19901 (25.00)18.7374
1990's1 (25.00)18.2507
2000's2 (50.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Chhokar, VS2
Sun, Y2
Bhattacharya, SK2
Ahokas, RA1
Myers, LK1
Xing, Z1
Smith, RA1
Gerling, IC1
Weber, KT2
Runyan, AL1
Runyan, JW1
Moghetti, P1
Castello, R1
Zamberlan, N1
Rossini, M1
Gatti, D1
Negri, C1
Tosi, F1
Muggeo, M1
Adami, S1
Lagrue, G1
Fournier, A1

Trials

1 trial available for spironolactone and Bone Loss, Osteoclastic

ArticleYear
Spironolactone, but not flutamide, administration prevents bone loss in hyperandrogenic women treated with gonadotropin-releasing hormone agonist.
    The Journal of clinical endocrinology and metabolism, 1999, Volume: 84, Issue:4

    Topics: Adult; Bone and Bones; Bone Density; Bone Resorption; Female; Flutamide; Hirsutism; Humans; Polycyst

1999

Other Studies

3 other studies available for spironolactone and Bone Loss, Osteoclastic

ArticleYear
Hyperparathyroidism and the calcium paradox of aldosteronism.
    Circulation, 2005, Feb-22, Volume: 111, Issue:7

    Topics: Aldosterone; Animals; Bone Density; Bone Resorption; Calcium; Hyperaldosteronism; Hyperparathyroidis

2005
Bone loss in rats with aldosteronism.
    The American journal of the medical sciences, 2005, Volume: 330, Issue:1

    Topics: Animals; Bone Resorption; Calcium; Hydrochlorothiazide; Hyperaldosteronism; Magnesium; Male; Parathy

2005
[Nephrology in 1972].
    La Revue du praticien, 1972, May-21, Volume: 22, Issue:15

    Topics: Bone Resorption; Calcium; Dextrans; Female; Fluorescent Antibody Technique; Gentamicins; Glomerulone

1972